CD8+/PD-1+ cells, a parameter for TIL activity, were significantly lower in HPD group than in the PR/CR group, and the degree of immune cell penetration into the tumor region did not increase (Fig. 3a). The gene discussed is CD8A; the disease is neoplasm.